期刊文献+

肠复康对人结肠癌细胞HT-29增殖及浸润转移的影响 被引量:4

Effect of changfukang on proliferation and infiltration of human colorectal carcinoma cell HT-29
原文传递
导出
摘要 [目的 ]探讨肠复康中药对人结肠癌细胞HT 2 9增殖及浸润转移影响的分子机制。 [方法 ]采用体外培养 ,应用免疫组化方法 ,检测其对核增殖抗原Ki 6 7、金属基质蛋白酶 (MMP2 )及其相应组织抑制物 (TIMP2 )表达的影响。 [结果 ]经中药血清处理过的HT 2 9细胞表现出增殖受抑 ,MMP2 表达减少及TIMP2 分泌增加 ,且其表达与中药血清浓度有量效关系 ,以 30 %血清组效果最明显。 [结论 ]中药肠复康通过抑制Ki 6 7的表达及影响MMP2 、TIMP2 的相互平衡来影响结肠癌细胞的增殖及浸润转移。 Objective] To explore the effect of changfukang recipe on proliferation and infiltration of human colorectal carcinoma cell HT 29 and its mechanism. [Methods] Cell culture and immunohistochemistry were applied to detect the expression of nuclear product antigen ( Ki 67), matrix metalloproteinases 2( MMP 2 ) and its tissue inhibitor (TIMP 2). [Results] The expression of Ki 67, MMP 2, TIMP 2 were observed following the treatment by drug serum of changfukang. The expression of both Ki 67 and MMP 2 decreased while the excretion of TIMP 2 increased, which showed dosage dependent. The effect of 30% changfukang serum on carcinoma cells was the most obvious.. [Conclusion] Proliferation and infiltration of colorectal carcinoma cells could be inhibited by changfukang recipe and its mechanism might be related with inhibiting the expression of nuclear product antigen Ki 67 and affecting the mutual balance between MMP 2 and TIMP 2 .
出处 《中国中西医结合消化杂志》 CAS 2004年第6期341-343,共3页 Chinese Journal of Integrated Traditional and Western Medicine on Digestion
基金 四川省教育厅重点资助课题 (NoOILA5 7)
关键词 人结肠癌细胞 肠复康 血清药理学 肿瘤细胞转移 HT-29 human colorectal carcinoma cell changfukang seropharmacology infiltration and metastasis HT-29
  • 相关文献

参考文献7

二级参考文献12

  • 1王伟,陈可冀,史大卓,钟蓓,朱应葆.精制血府胶囊对缺氧缺糖心肌细胞一氧化氮合酶基因表达的影响[J].中国中西医结合杂志,1996,16(11):670-672. 被引量:21
  • 2鄂征.组织培养技术,第2版[M].北京:人民卫生出版社,1993.127-128. 被引量:4
  • 3Kong H L, Crystal R G. Gene therapy strategies for tumor antiangiogenesis. J Natl Cancer Inst, 1998,90.. 273. 被引量:1
  • 4Zatterstrom U K, Felbor U, Fukai N, et al. Collagen XV Ⅲ/endostain structure and functional role in angiogenesis. Cell Struct Funct, 2000,25: 97. 被引量:1
  • 5Kimura H,Nakajima T, Kagawa K,et al. Angiogenesis in hepatocellular carcinoma as evaluated by CD34 immunohistochemistry. Liver, 1998, 18 : 14. 被引量:1
  • 6Ryan C J ,Wilding G. Angiogenesis inhibitors. New agents in cancer therapy. Drugs Aging, 2000,17: 249. 被引量:1
  • 7Nor J E,Christensen J, Mooney D J,et al. Vascular endothelial growth factor (VEGF) -mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol, 1999,154 : 375. 被引量:1
  • 8Jinno K,Tanimizu M, Hyodo J,et al. Circulating vascular endothelial growth factor (VEGF) is a possible tumor marker for metastasis in human hepatocellular carcinoma.J Gastroenterol, 1998,33 : 376. 被引量:1
  • 9Chen C T,Lin J,Li Q,et al. Antiangiogenic gene therapy for cancer via systemic administration of adenoviral vectors expressing secretable endostatin. Hum Gene Ther,2000,11 : 1983. 被引量:1
  • 10王伟,中国中西医结合杂志,1996年,16卷,1期,670页 被引量:1

共引文献211

同被引文献84

引证文献4

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部